Home » Authors » Trista Morrison

Articles by Trista Morrison

CytRx Spins Out RNAi Programs To Form Subsidiary RXi Pharma

Jan. 11, 2007

By Trista Morrison

CytRx Spins Out RNAi Programs To Form Subsidiary RXi Pharma

Jan. 11, 2007

By Trista Morrison

Biogen Idec Acquires Syntonix, Moves Into Hemophilia Arena

Jan. 5, 2007

By Trista Morrison

Biogen Idec Acquires Syntonix, Moves Into Hemophilia Arena

Jan. 5, 2007

By Trista Morrison

Biomira Launches Clinical Trials Of Cancer-Fighting Therapies

Jan. 3, 2007

By Trista Morrison

Biomira Launches Clinical Trials Of Cancer-Fighting Therapies

Jan. 3, 2007

By Trista Morrison

Paramount-Backed Tikvah Makes Reduced-Risk CNS Play

Dec. 29, 2006

By Trista Morrison

Paramount-Backed Tikvah Makes Reduced-Risk CNS Play

Dec. 29, 2006

By Trista Morrison

EpiCept Licenses Bupivacaine Patch IP To Durect For $10M

Dec. 27, 2006

By Trista Morrison

Ardea Biosciences Acquires Valeant's Early Programs

Dec. 27, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.